SCHEMBL11233016

SCHEMBL11233016

CCc1[nH]c(=O)c(C(N)=NO)cc1-c1cccnc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
MKNK1 Q9BUB5 7/20 0.39
MKNK2 Q9HBH9 7/20 0.39
CYP2E1 P05181 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2A6 P11509 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2B6 P20813 1/20 0.38
CYP2C19 P33261 1/20 0.38
CDC7 O00311 1/20 0.38
BTK Q06187 1/20 0.38
AURKA O14965 1/20 0.37
TTK P33981 1/20 0.37
AURKB Q96GD4 1/20 0.37
INCENP Q9NQS7 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11231128 0.87 MKNK1 (0.49) PDE3BPDE3AMKNK1MKNK2CDC7
SCHEMBL11229059 0.84 MKNK1 (0.43) PDE3BPDE3AMKNK1MKNK2CYP2C19
SCHEMBL11234641 0.83 PDE3B (0.44) PDE3BPDE3AMKNK1MKNK2CYP2E1
SCHEMBL11236049 0.81 CCNC (0.41) PDE3BPDE3AMKNK2CDC7
SCHEMBL11231551 0.80 AURKB (0.51) PDE3BPDE3AMKNK1MKNK2CYP2E1
SCHEMBL11233012 0.80 PDE3B (0.42) PDE3BPDE3AMKNK1MKNK2CYP2E1
SCHEMBL11236586 0.79 CDK5 (0.53) PDE3BPDE3ACDC7KDM4EALDH1A1
SCHEMBL11235886 0.78 PDE3B (0.46) PDE3BPDE3AMKNK1MKNK2CYP2E1
SCHEMBL11228422 0.76 PDE3B (0.49) PDE3BPDE3ACDC7AURKBINCENP
SCHEMBL11223231 0.75 PDE3B (0.48) PDE3BPDE3ACDC7AURKBINCENP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4339584-A Process for preparing 3-amino-5-(pyridinyl)-2(1H)-pyridinones via N-hydroxy-1,2-dihydro-2-oxo-5-(pyridinyl)-nicotinimidamide by reaction with polyphosphoric acid STERLING DRUG INC. (US) 1982-07-13 US disclosed
US-4305948-A N-Hydroxy-1,2-dihydro-2-oxo-5-(pyridinyl)-nicotinimidamide and their cardiotonic use STERLING DRUG INC. (US) 1981-12-15 US disclosed